Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 30;14(8):e28605.
doi: 10.7759/cureus.28605. eCollection 2022 Aug.

Inflammation as a Prognostic Marker in Heart Failure

Affiliations

Inflammation as a Prognostic Marker in Heart Failure

Priscila C Lima et al. Cureus. .

Abstract

Background: Heart failure (HF) is a chronic cardiac disease of great importance worldwide and responsible for one-fifth of hospitalizations for cardiovascular disease in Brazil. Pro-inflammatory mediators are involved in the pathophysiology of HF. However, the impact of inflammatory markers on the prognosis of the disease remains uncertain.

Objective: We aimed to evaluate inflammation as a prognostic marker in chronic HF.

Methods: In this prospective, single-center, observational cohort study conducted from June 2018 through December 2019, we included outpatients with HF from a specialized service of a teaching hospital. Patients with decompensated HF requiring hospitalization in the last 30 days were excluded. At the time of inclusion, serum C-reactive protein (CRP) and albumin were collected and the presence of inflammation was defined as CRP/albumin ≥1.2. Patients with CRP/albumin ratio <1.2 (group A) and CRP/albumin ratio ≥1.2 (group B) were compared. The primary outcome was all-cause mortality. The secondary outcomes were hospitalization for decompensated HF, number of hospitalizations, and number of days of hospitalization in the 12-month follow-up.

Results: We included 77 patients, 49 (63.3%) in group A and 28 (3.4%) in group B. Six patients in group A (12.2%) and 10 patients in group B (35.7%) required at least one hospitalization during follow-up (p=0.01). The rate of hospitalizations for decompensated HF for every 100 patients was 16.3 in group A vs 50.0 in group B (p=0.0001) and the average in-hospital length of stay was 12.2 vs 14.2 days per hospitalized patient (p=0.36) in groups A and B, respectively. The mortality rate was 6.1% in group A vs 7.1% in group B (p=0.86).

Conclusion: In HF outpatients with inflammation evidentiated by the CRP/albumin ratio ≥1.2, the risk of death was similar to patients without inflammation criteria. However, the presence of inflammation led to a three-fold higher risk of hospitalization for HF decompensation.

Keywords: albumin; c-reactive protein; heart failure; hospitalization; inflammation; prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Hunt SA, Abraham WT, Chin MH, et al. Circulation. 2005;112:0–235. - PubMed
    1. I Brazilian Registry of Heart Failure - Clinical aspects, care quality and hospitalization outcomes. Albuquerque DC, Neto JD, Bacal F, Rohde LE, Bernardez-Pereira S, Berwanger O, Almeida DR. Arq Bras Cardiol. 2015;104:433–442. - PMC - PubMed
    1. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Mann DL. Circ Res. 2002;91:988–998. - PubMed
    1. Immune activation in chronic heart failure. Torre-Amione G. Am J Cardiol. 2005;95:3–8. - PubMed
    1. Hypoalbuminemia in hospitalized patients with community-acquired pneumonia. Hedlund JU, Hansson LO, Ortqvist AB. Arch Intern Med. 1995;155:1438–1442. - PubMed

LinkOut - more resources